FRANCE BED HOLDINGS CO., LTD.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3826500005
JPY
1,241.00
-22 (-1.74%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Japan Lifeline Co., Ltd.
Jins Holdings, Inc.
FRANCE BED HOLDINGS CO., LTD.
Mani, Inc.
Fukuda Denshi Co., Ltd.
Medikit Co., Ltd.
Menicon Co., Ltd.
PHC Holdings Corp.
Eiken Chemical Co., Ltd.
Hogy Medical Co., Ltd.
Takara Bio, Inc.

Why is FRANCE BED HOLDINGS CO., LTD. ?

1
Poor Management Efficiency with a low ROE of 7.20%
  • The company has been able to generate a Return on Equity (avg) of 7.20% signifying low profitability per unit of shareholders funds
2
Weak Long Term Fundamental Strength with a 3.63% CAGR growth in Net Sales over the last 5 years
  • The company has been able to generate a Return on Equity (avg) of 7.20% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 3.63% over the last 5 years
4
Flat results in Mar 26
  • ROCE(HY) Lowest at 6.8%
  • INTEREST(Q) At JPY 19 MM has Grown at 11.76%
  • DEBT-EQUITY RATIO (HY) Highest at 5.83 %
5
With ROE of 7.01%, it has a very attractive valuation with a 1.10 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -4.61%, its profits have fallen by -15.4%
6
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -4.61% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to FRANCE BED HOLDINGS CO., LTD. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is FRANCE BED HOLDINGS CO., LTD. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
FRANCE BED HOLDINGS CO., LTD.
-100.0%
0.27
15.66%
Japan Nikkei 225
59.79%
2.03
29.50%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
3.63%
EBIT Growth (5y)
8.08%
EBIT to Interest (avg)
55.90
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.05
Sales to Capital Employed (avg)
1.15
Tax Ratio
35.43%
Dividend Payout Ratio
49.97%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
11.50%
ROE (avg)
7.20%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
1.10
EV to EBIT
9.27
EV to EBITDA
4.29
EV to Capital Employed
1.10
EV to Sales
0.68
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
11.85%
ROE (Latest)
7.01%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
DIVIDEND PER SHARE(HY)

Highest at JPY 5.6

RAW MATERIAL COST(Y)

Fallen by 1.63% (YoY

NET SALES(Q)

Highest at JPY 16,959 MM

NET PROFIT(Q)

Highest at JPY 930.17 MM

EPS(Q)

Highest at JPY 22.58

-5What is not working for the Company
ROCE(HY)

Lowest at 6.8%

INTEREST(Q)

At JPY 19 MM has Grown at 11.76%

DEBT-EQUITY RATIO (HY)

Highest at 5.83 %

Here's what is working for FRANCE BED HOLDINGS CO., LTD.

Dividend per share
Highest at JPY 5.6 and Grown
In each year in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (JPY)

Net Sales
Highest at JPY 16,959 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (JPY MM)

Net Profit
Highest at JPY 930.17 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (JPY MM)

EPS
Highest at JPY 22.58
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (JPY)

Raw Material Cost
Fallen by 1.63% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at JPY 1,342 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (JPY MM)

Here's what is not working for FRANCE BED HOLDINGS CO., LTD.

Interest
At JPY 19 MM has Grown at 11.76%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Debt-Equity Ratio
Highest at 5.83 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio